With telehealth surging around the globe due to the COVID-19 pandemic, the UK National Health Services has released guidance that provides a set of good practice principles for third-party partners to follow....more
2/5/2021
/ Coronavirus/COVID-19 ,
Data Protection ,
Electronic Protected Health Information (ePHI) ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Infectious Diseases ,
Life Sciences ,
Patient Access ,
Personal Data ,
Regulatory Agenda ,
Telehealth ,
Telemedicine ,
UK
Welcome to the third issue of our European Life Sciences Review that covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last month and is produced by our life sciences...more
7/16/2016
/ Anti-Competitive ,
Anti-Corruption ,
Clinical Trials ,
Data Protection ,
EU ,
EU-US Privacy Shield ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Medical Devices ,
Mobile Health Apps ,
Off-Label Promotion ,
Pharmaceutical Industry ,
TTIP ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA)
The European Medicines Agency moves to increase EU clinical trial transparency.
The last five years have seen a sea change in the attitude of EU authorities regarding the disclosure of clinical trial results, moving from...more
8/5/2015
/ Clinical Trials ,
Confidential Information ,
Data Privacy ,
Data Protection ,
Data-Sharing ,
EU ,
Medical Research ,
New Regulations ,
Personally Identifiable Information ,
PHRMA ,
Transparency